Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children
Department of Pediatrics; Program in Molecular Medicine
Bacterial Vaccines; Child, Preschool; HIV Infections; HIV-1; Humans; Immunologic Memory; Infant; *Vaccination; Vaccines, Attenuated; Vaccines, Subunit; Viral Vaccines; Virus Replication
Immunology and Infectious Disease | Pediatrics
Children infected by HIV-1 are particularly vulnerable to severe, recurrent, or unusual infections by vaccine-preventable pathogens. Routine immunisations seem to be generally safe for HIV-1-infected children, but responses may be suboptimal. Early HIV-1-induced immune attrition associated with viral replication may particularly interfere with the development of memory responses. In high HIV-1 prevalence regions, the accumulation of susceptible hosts may compromise disease-control efforts. Although early control of viral replication through treatment with highly active therapy may preserve immune function and responses to routine childhood vaccines, availability is limited in the areas most affected. In this review, we provide an overview of the immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. The possible immunological bases for defective responses are discussed; unanswered questions and the need for further research are delineated.
DOI of Published Version
Lancet Infect Dis. 2004 Aug;4(8):510-8. Link to article on publisher's site
The Lancet infectious diseases
Obaro, S. K.; Pugatch, D.; and Luzuriaga, Katherine, "Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children" (2004). Immunology/Infectious Disease. 43.